• Explore /
  • Poster
  • / Clonal expansion of tumor infiltrating lymphocytes (TILs) in the peripheral blood of metastatic melanoma patients is significantly associated with response to CTLA4 blockade-based immunotherapy.

Clonal expansion of tumor infiltrating lymphocytes (TILs) in the peripheral blood of metastatic melanoma patients is significantly associated with response to CTLA4 blockade-based immunotherapy.

Abstract Poster

Authors

null

Arjun Khunger

Cleveland Clinic, Cleveland, OH

Arjun Khunger , Julie Rytlewski , Erik C. Yusko , Ahmad A. Tarhini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Immunotherapy and Tumor Immunobiology

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Circulating Biomarkers

Citation

J Clin Oncol 37, 2019 (suppl; abstr 2541)

DOI

10.1200/JCO.2019.37.15_suppl.2541

Abstract #

2541

Poster Bd #

185

Abstract Disclosures

Similar Posters

First Author: Morten Nielsen

Poster

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).

Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).

First Author: John Yi

First Author: Ahmad A. Tarhini

First Author: Courtney Regan